SCHEMBL20819590

SCHEMBL20819590

COc1cc(C)cc(O)c1C1(C(=O)O)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ ERN1 O75460 1/20 0.38
▸ POLB P06746 4/20 0.38
▸ RECQL P46063 4/20 0.38
▸ KDM4E B2RXH2 3/20 0.38
▸ MAPT P10636 3/20 0.38
▸ PKM P14618 2/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ ABL1 P00519 1/20 0.38
▸ BLM P54132 1/20 0.38
▸ BCL2L1 Q07817 1/20 0.38
▸ MCL1 Q07820 1/20 0.38
▸ RIN1 Q13671 1/20 0.38
▸ SAE1 Q9UBE0 1/20 0.38
▸ UBA2 Q9UBT2 1/20 0.38
▸ GAA P10253 2/20 0.37
▸ PTGS2 P35354 1/20 0.37
▸ CNR2 P34972 2/20 0.36
▸ ACHE P22303 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20819588 0.90 ALDH1A1 (0.45) ALDH1A1SMN1; SMN2ERN1CNR2ACHE
SCHEMBL20819553 0.86 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2ERN1MAPTPKM
SCHEMBL20819684 0.85 SELL (0.39) KDM4EACHEKMT2ATPMT
SCHEMBL20819548 0.81 LPAR1 (0.46) ALDH1A1SMN1; SMN2LPAR1KMT2A
SCHEMBL20819605 0.81 TSHR (0.42) ALDH1A1SMN1; SMN2MAPTNPC1LPAR1
SCHEMBL20819567 0.77 PTGDR2 (0.40) ALDH1A1SMN1; SMN2ERN1LPAR1
SCHEMBL20819536 0.76 CYP3A4 (0.36) ALDH1A1POLBKDM4EMAPTCA2
SCHEMBL31045607 0.75 MAP3K14 (0.41) ALDH1A1ERN1POLBKDM4EMAPT
SCHEMBL20819549 0.74 HPGD (0.40) ALDH1A1POLBKDM4EMAPTKMT2A
SCHEMBL20819570 0.73 KMT2A (0.38) SMN1; SMN2NPC1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3681864-A1 MODULATORS OF THE CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR PROTEIN AND METHODS OF USE AbbVie Overseas S.à r.l. (LU) 2020-07-22 — — EP disclosed
WO-2019053634-A1 MODULATORS OF THE CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR PROTEIN AND METHODS OF USE AbbVie S.à.r.l. (LU) 2019-03-21 — — WO disclosed
Send feedback